Bionano Genomics, Inc. (BNGO)
BNGO moved a median of -0.94% 30 minutes after news, and -1.60% by the close. How BNGO actually reacts to news — the realized, point-in-time move the market made, measured across 321 labeled events over the last three years with zero look-ahead.
BNGO’s median reaction, across the day.
| Horizon | Median | % positive | Events |
|---|---|---|---|
| 5-min | -0.38% | 31% | 317 |
| 30-min | -0.94% | 31% | 319 |
| 60-min | -0.98% | 30% | 319 |
| to close | -1.60% | 28% | 320 |
| Middle 50% of BNGO reactions | -3.11% to +0.62% |
|---|---|
| Median reaction (30-min) | -0.94% |
| Measured reactions | 321 |
Half of all Bionano Genomics, Inc. news events land between -3.11% and +0.62% at 30 minutes.
Reaction stats as of 2026-09-21. Newest measured event . Reaction = percent move vs. the price at the news timestamp.
How BNGO reacts, by analyst action.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst downgrades | 10 | -1.92% | 0% | -0.61% |
| Rating reiterations | 12 | -1.65% | 8% | +2.10% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The same measurement runs across every name in the dataset. 4 further classes were observed with fewer than 10 measured events and are not published. See how BNGO ranks against every other measured name →
That’s how BNGO usually reacts — get an email when it moves on news →Email me when BNGO moves on news.
One email per qualifying move — the headline, the measured reaction, and how it compares to BNGO's baseline. Nothing else.
Recent BNGO events, each with its measured reaction.
| Date | Headline | Event | Source | 5-min | To close |
|---|---|---|---|---|---|
| Bionano Announces Three New Peer-Reviewed Studies Demonstrate Clinical Value of Bionano's Optical Genome Mapping Across Myelodysplastic Syndromes and Acute Myeloid Leukemia | Press release | GlobeNewswire | -1.28% | +8.13% | |
| Form 8-K Bionano Genomics, Inc. For: Sep 14 | SEC filing · Form 8-K | SEC EDGAR | -1.28% | +8.13% | |
| Bionano Laboratories Announces Proposed Local Coverage Determination (LCD) from MolDX for Genome-Wide Detection of Structural Variants in Hematologic Neoplasms | Press release | GlobeNewswire | +0.00% | +1.70% | |
| Bionano to Participate in the H.C. Wainwright 28th Annual Global Investment Conference | Press release | GlobeNewswire | -0.95% | +0.00% | |
| Bionano to Report Second Quarter 2026 Financial Results and Host a Conference Call Webcast on August 10, 2026 | Press release | GlobeNewswire | +0.00% | +0.00% | |
| Bionano Announces Hiring of Chief Scientific Officer | Press release | GlobeNewswire | +2.21% | +0.00% | |
| Form 8-K Bionano Genomics, Inc. For: Jun 24 | SEC filing · Form 8-K | SEC EDGAR | +2.21% | +0.00% | |
| Bionano Announces 67% Year-Over-Year Growth in Studies Featuring Optical Genome Mapping at ESHG 2026, Reflecting Expanding Global Adoption | Press release | GlobeNewswire | -0.85% | -3.39% | |
| Bionano Announces Multiple Publications in 2026 Describing Unique Utility of OGM in Studies of Reproductive Health and Prenatal Genetic Disorders | Press release | GlobeNewswire | -0.86% | +1.71% | |
| Form 8-K Bionano Genomics, Inc. For: Jun 02 | SEC filing · Form 8-K | SEC EDGAR | -0.89% | -2.50% | |
| Bionano Announces Full Retirement of Outstanding Senior Secured Convertible Debentures | Press release | GlobeNewswire | +0.81% | +0.81% | |
| Form 8-K Bionano Genomics, Inc. For: May 28 | SEC filing · Form 8-K | SEC EDGAR | +0.81% | +0.81% | |
| Bionano Announces Largest OGM Study of T-Cell Acute Lymphoblastic Leukemia | Press release | GlobeNewswire | +0.00% | -1.61% | |
| Form 8-K Bionano Genomics, Inc. For: May 14 | SEC filing · Form 8-K | SEC EDGAR | -0.84% | -3.36% | |
| Bionano Reports First Quarter 2026 Results and Provides a Business Update | Press release | GlobeNewswire | -0.78% | -7.03% | |
| Form 10-Q Bionano Genomics, Inc. For: Mar 31 | SEC filing · Form 10-Q | SEC EDGAR | -0.78% | -7.03% | |
| Form 8-K Bionano Genomics, Inc. For: May 13 | SEC filing · Form 8-K | SEC EDGAR | -0.78% | -7.03% | |
| Form S-3 Bionano Genomics, Inc. | SEC filing · Form S-3 | SEC EDGAR | +0.78% | -1.55% | |
| Bionano Announces Leadership Transition | Press release | GlobeNewswire | -0.79% | +5.56% | |
| Form 8-K Bionano Genomics, Inc. For: May 05 | SEC filing · Form 8-K | SEC EDGAR | -0.79% | +5.56% | |
| Bionano Announces a 56% Increase in Publications Describing the Utility of OGM in Rare Diseases in Q1 2026 vs Q1 2025 | Press release | GlobeNewswire | +1.59% | -1.59% | |
| Bionano to Report First Quarter 2026 Financial Results and Host a Conference Call Webcast on May 13, 2026 | Press release | GlobeNewswire | +0.85% | -0.85% | |
| Bionano Announces Publication from Johns Hopkins and MD Anderson Showing that OGM can Outperform Traditional Methods in Analysis of Multiple Myeloma | Press release | GlobeNewswire | +0.00% | +1.70% | |
| Form ARS Bionano Genomics, Inc. For: Dec 31 | SEC filing · Form ARS | SEC EDGAR | +0.00% | -3.36% | |
| Form DEF 14A Bionano Genomics, Inc. For: Apr 01 | SEC filing · Form DEF | SEC EDGAR | +0.00% | -3.36% | |
| Form DEFA14A Bionano Genomics, Inc. | SEC filing · Form DEFA14A | SEC EDGAR | +0.00% | -3.36% | |
| Form S-8 Bionano Genomics, Inc. | SEC filing · Form S-8 | SEC EDGAR | +2.54% | -2.54% | |
| Bionano Reports Fourth Quarter and Full-Year 2025 Results and Provides Revenue Outlook for 2026 | Press release | GlobeNewswire | -0.15% | -9.23% | |
| Form 10-K Bionano Genomics, Inc. For: Dec 31 | SEC filing · Form 10-K | SEC EDGAR | -0.15% | -9.23% | |
| Form 8-K Bionano Genomics, Inc. For: Mar 23 | SEC filing · Form 8-K | SEC EDGAR | -0.15% | -9.23% | |
| Bionano Announces Two-Fold Increase in OGM Studies Presented at the 2026 American College of Medical Genetics and Genomics (ACMG) Annual Clinical Genetics Meeting | Press release | GlobeNewswire | +0.00% | +2.73% | |
| Bionano to Report Fourth Quarter and Full Year 2025 Financial Results and Host a Conference Call Webcast on March 23, 2026 | Press release | GlobeNewswire | +0.00% | +0.89% | |
| Bionano Symposium 2026 Concluded with 9 Speakers Describing the Breadth of Bionano Solutions and Their Potential for Use on a Large Scale | Press release | GlobeNewswire | -0.43% | -0.86% | |
| 10 Presentations on Day 3 of Bionano Symposium 2026 Showcase OGM’s Utility in Unraveling the Complex Puzzles of Constitutional Genetic Disorders | Press release | GlobeNewswire | -0.66% | -0.86% | |
| 11 Presentations on Day 2 of Bionano Symposium 2026 Showcase Expanding Impact of Optical Genome Mapping Across Oncology and Cell & Gene Therapy | Press release | GlobeNewswire | +2.61% | +0.00% | |
| 9 Presentations Kick Off Day 1 of the Bionano Symposium 2026 Covering Advances in Optical Genome Mapping for Hematologic Malignancies | Press release | GlobeNewswire | -0.45% | +0.00% | |
| Bionano Announces Bionano Symposium 2026: Global Experts Showcase Advances and Innovation in Optical Genome Mapping | Press release | GlobeNewswire | -1.63% | +0.00% | |
| Bionano Announces Publication from Sanford Burnham Prebys Medical Discovery Institute Describing use of OGM to Detect Genomic Alterations Introduced by Gene Editing Technologies | Press release | GlobeNewswire | -0.83% | -1.25% | |
| Bionano Reports Preliminary Fourth Quarter and Full-Year 2025 Results | Press release | GlobeNewswire | +0.00% | -0.63% | |
| Form 8-K Bionano Genomics, Inc. For: Jan 12 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | -0.63% | |
| Bionano Recaps Advances in Optical Genome Mapping Showcased at AMP 2025 | Press release | GlobeNewswire | +0.59% | -1.19% | |
| Final 2026 Clinical Lab Fee Schedule Indicates a 47% Increase in Payment Determination for the Category I CPT Code for OGM use in Hematologic Malignancies | Press release | GlobeNewswire | +4.13% | +2.98% | |
| Bionano Announces Publication Showing OGM Can Overcome Key Limitations of Targeted RNA-Seq for Cytogenetic Investigation in Acute Leukemia | Press release | GlobeNewswire | -1.84% | -5.29% | |
| Bionano to Report Third Quarter 2025 Financial Results and Host a Conference Call Webcast on November 13, 2025 | Press release | GlobeNewswire | -1.62% | -2.70% | |
| Bionano Highlights Global Momentum Behind OGM at the 2025 Annual Meeting of the American Society of Human Genetics (ASHG) Meeting | Press release | GlobeNewswire | -0.64% | -1.04% | |
| Bionano to Participate in the H.C. Wainwright @ Home Event | Press release | GlobeNewswire | -0.49% | -1.95% | |
| Form 8-K Bionano Genomics, Inc. For: Sep 16 | SEC filing · Form 8-K | SEC EDGAR | +0.00% | +0.00% | |
| Bionano Genomics, Inc. Announces Closing of $10 Million Public O?ering | Press release | GlobeNewswire | +0.00% | +0.00% | |
| Form EFFECT Bionano Genomics, Inc. | SEC filing · Form EFFECT | SEC EDGAR | +3.42% | -0.56% | |
| Bionano Genomics, Inc. Announces Pricing of $10 Million Public O?ering | Press release | GlobeNewswire | -0.06% | +11.25% |
Each reaction is the move the market actually made, measured from the news timestamp. Headlines link through to the BNGO section they belong to.
Where else BNGO is measured.
BNGO earnings → · Analyst actions → · SEC filings →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| Theravance Biopharma, Inc. - Ordinary Shares (TBPH) | 326 | +0.10% | 57% |
| Verona Pharma plc - American Depositary Shares (VRNA) | 325 | -0.03% | 39% |
| Wave Life Sciences, Inc. (WVE) | 321 | -0.14% | 45% |
| Pulse Biosciences, Inc (PLSE) | 320 | +0.18% | 55% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.
All Healthcare names, measured the same way →
Every ticker we measure the same way24
Apple (AAPL)
How AAPL actually reacts to news, measured.
NVIDIA (NVDA)
How NVDA actually reacts to news, measured.
Tesla (TSLA)
How TSLA actually reacts to news, measured.
Microsoft (MSFT)
How MSFT actually reacts to news, measured.
Advanced Micro Devices (AMD)
How AMD actually reacts to news, measured.
Amazon (AMZN)
How AMZN actually reacts to news, measured.
Alphabet (GOOG)
How GOOG actually reacts to news, measured.
Meta Platforms (META)
How META actually reacts to news, measured.
Broadcom (AVGO)
How AVGO actually reacts to news, measured.
JPMorgan Chase (JPM)
How JPM actually reacts to news, measured.
Visa (V)
How V actually reacts to news, measured.
Walmart (WMT)
How WMT actually reacts to news, measured.
Eli Lilly (LLY)
How LLY actually reacts to news, measured.
UnitedHealth Group (UNH)
How UNH actually reacts to news, measured.
Netflix (NFLX)
How NFLX actually reacts to news, measured.
Johnson & Johnson (JNJ)
How JNJ actually reacts to news, measured.
Exxon Mobil (XOM)
How XOM actually reacts to news, measured.
Home Depot (HD)
How HD actually reacts to news, measured.
Costco (COST)
How COST actually reacts to news, measured.
Mastercard (MA)
How MA actually reacts to news, measured.
Oracle (ORCL)
How ORCL actually reacts to news, measured.
Salesforce (CRM)
How CRM actually reacts to news, measured.
Bank of America (BAC)
How BAC actually reacts to news, measured.
Coca-Cola (KO)
How KO actually reacts to news, measured.
Walt Disney (DIS)
How DIS actually reacts to news, measured.
Browse all tickers
Every name we’ve measured, in one place.
How the numbers are made.
How is Bionano Genomics, Inc.'s median reaction calculated?
Every labeled BNGO news event is measured from its own timestamp: the last trade before the news is the base price, and the move is read at fixed horizons — 30 minutes of trading, then the close. The median across 321 events is what this page reports. Point-in-time, zero look-ahead: no event borrows information from a later one.
What counts as a positive reaction?
Any event whose price move is above zero at the horizon, relative to the last trade before the news timestamp. 31% of BNGO's measured events are up at 30 minutes; the rest close the window flat or negative.
How often is this page updated?
The news table refreshes automatically as new events are labeled and priced. The reaction medians are re-pulled in batches from the dataset — the figures here are as of 2026-09-21.
Does BNGO's past reaction predict its next one?
No. These are realized facts about past events, not forecasts. They describe a distribution — they say nothing certain about any future move.